Domov › Ulcerózna kolitída › Virginia
Klinické štúdie Ulcerózna kolitída v štáte Virginia
14 štúdií pre Ulcerózna kolitída hľadá účastníkov v zariadeniach v štáte Virginia.
Mestá v štáte Virginia
Oficiálny text štúdie (anglicky)
Extension Study of Long-term Safety and Efficacy of Tulisokibart in Participants With Crohn's Disease or Ulcerative Colitis (MK-7240-011)
- University of Virginia Health System ( Site 0291), Charlottesville
Prebieha náborFáza 3
Všetky vekové kategórie · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06651281Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
- Emeritas Research Group /ID# 284388, Lansdowne Town Center
- GI Alliance - Richmond /ID# 284244, Richmond
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT07697456A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
- Gastroenterology Consultants of Southwest Virginia., Roanoke
Prebieha náborFáza 4
Vek 18 až 80 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT06581328Study of XmAb942 in Healthy Participants and Participants With Ulcerative Colitis
- Xencor Investigative Site, Richmond
Prebieha náborFáza 1/2Vítaní zdravých dobrovoľníkov
Vek 18 až 75 · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT06619990A Trial to Investigate PALI-2108 Versus Placebo in Participants With Moderately to Severely Active Ulcerative Colitis
- Site US-013, Richmond
Prebieha náborFáza 2
Vek 18 až 75 · Všetky pohlavia · Aktualizované 29. 9. 2026 · NCT07845487A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
- Gastroenterology Associates of Tidewater, Chesapeake
- Blue Ridge Medical Research, Lynchburg
Prebieha náborFáza 3
Vek 12 a viac · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07196748Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
- Gastroenterology Consultants of Southwest Virginia, Roanoke
Prebieha náborFáza 3
Vek 18 až 70 · Všetky pohlavia · Aktualizované 24. 9. 2026 · NCT06937086Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- VCU Massey Comprehensive Cancer Center, Richmond
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT03816345LY4268989 (MORF-057) Co-Administered With Mirikizumab in Adults With Moderately to Severely Active Ulcerative Colitis:
- Clinical Research Partners, LLC, Richmond
- GI Alliance - Richmond, Richmond
- Carilion Clinic, Roanoke
Prebieha náborFáza 2
Vek 18 až 80 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07186101A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Pediatric Specialists of Virginia, Fairfax
Prebieha náborFáza 3
Vek 2 až 19 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT04844606LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
- Eximia Research-VA, LLC, Norfolk
Prebieha náborFáza 2
Vek 18 až 80 · Všetky pohlavia · Aktualizované 22. 9. 2026 · NCT07415044An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
- Blue Ridge Medical Research - Site Number: 8400020, Lynchburg
- Clinical Research Partners - Site Number: 8400080, Richmond
Prebieha náborFáza 3
Vek 16 až 80 · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT07184996A Study of Vedolizumab in Children With Ulcerative Colitis (UC) or Crohn's Disease (CD)
- Carilion Children's Tanglewood Center, Roanoke
Prebieha náborFáza 3
Vek 2 a viac · Všetky pohlavia · Aktualizované 7. 5. 2026 · NCT05442567Ketogenic and Carnivore (Lion) Diets for Inflammatory Bowel Disease and Rheumatoid Arthritis
- Resilient Roots: Functional Medicine, Charlottesville
Prebieha nábor
Vek 18 až 64 · Všetky pohlavia · Aktualizované 16. 4. 2026 · NCT07524244Z ClinicalTrials.gov, dáta načítané 4. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.